A new treatment option for Intermediate-2 and High-Risk MDS Patients
Tuesday 4 April 2023, 8.00pm AEST
Privacy Statement:
We collect personal information about you when you interact with us. We use this information to provide information about our products and stay in contact with you. You can find out more about the ways in which we use, handle and store personal information and how you can access your information at https://otsuka.com.au/privacy-policy/
References: 1. Pharmaceutical Benefits Scheme. Available at: http://www.pbs.gov.au Accessed March 2023
PBS Information: Authority Required. Refer to the PBS Schedule for full authority information.
PLEASE REVIEW THE FULL PRODUCT INFORMATION (PI) BEFORE PRESCRIBING.
THE APPROVED PI IS AVAILABLE HERE.
INQOVI® is a registered trademark of Otsuka Pharmaceutical Co. Ltd.
Otsuka Australia Pharmaceutical Pty Ltd, ABN 20 601 768 754. Chatswood NSW 2067.
Medical Information: 1800 059 606. www.otsuka.com.au. Date of Preparation: March 2023. INQ-AU-95
